Overview

Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer

Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the dose of WST11 and light energy necessary to obtain desobstruction of the bronchial lumen using Vascular Targeted Photodynamic therapy in obstructive Non-Small Cell Lung Cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Steba Biotech S.A.